NASDAQ: MRNS

Pennsylvania-based pharma company Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) has entered into a collaboration and supply agreement with China-based Tenacia Biotechnology (Shanghai) Co., Ltd. Under the agreement, Tenacia will receive exclusive development and commercialization rights to certain formulations of Marinus’s ganaxolone in mainland China, Hong Kong, Macau, and Taiwan. The deal…